Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "hybrid"

65 News Found

JB Pharma publishes sustainability report for FY 2022-23
Sustainability | September 12, 2023

JB Pharma publishes sustainability report for FY 2022-23

JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions


Shilpa Medicare receives UK MHRA approval for mouth-dissolving strips to treat illnesses
News | September 03, 2023

Shilpa Medicare receives UK MHRA approval for mouth-dissolving strips to treat illnesses

This approval has come from the company's finished dosage form manufacturing facility


Evonik showcases smart technology for dental prostheses
News | July 05, 2023

Evonik showcases smart technology for dental prostheses

PEEK brings a new quality to dental care for patients


Novartis unveils results of survey on chronic myeloid leukemia
News | June 12, 2023

Novartis unveils results of survey on chronic myeloid leukemia

Survey of Unmet Needs in chronic myeloid leukemia (CML SUN) data signal need for amplified patient voice during treatment discussions that balance quality of life (QoL), efficacy, and tolerability goals across all lines of therapy


India committed to strengthen traditional medicine practice by bolstering evidence-based research: Sonowal
Policy | February 13, 2023

India committed to strengthen traditional medicine practice by bolstering evidence-based research: Sonowal

The Ministry of Ayush endeavour is to get entry level NABH certification for 12,500 Ayush Wellness Centers by the end of 2023


GSK announces new global headquarters in central London
News | December 12, 2022

GSK announces new global headquarters in central London

Company to open new headquarters in 2024


EMA accepts marketing authorisation application for momelotinib for the treatment of myelofibrosis
News | December 05, 2022

EMA accepts marketing authorisation application for momelotinib for the treatment of myelofibrosis

Application includes data from key phase III trials, including the pivotal MOMENTUM trial, which met all primary and key secondary efficacy endpoints


CPHI & PMEC India 2022 showcases array of machinery, ingredients and technology
Drug Approval | November 30, 2022

CPHI & PMEC India 2022 showcases array of machinery, ingredients and technology

South Asia’s largest exhibition for pharma brought together over 50,000 visitors from across the globe


CPhI and P-MEC India sees participation of over 1500 exhibitors
News | November 29, 2022

CPhI and P-MEC India sees participation of over 1500 exhibitors

40,000 visitors and representatives of more than 80 countries set to visit the show


CPhI & P-MEC India expo to encourage cost-effective solutions in India’s march towards a Rs 10.5 lakh crore pharma market by 2030
News | November 17, 2022

CPhI & P-MEC India expo to encourage cost-effective solutions in India’s march towards a Rs 10.5 lakh crore pharma market by 2030

The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees